APR 03, 2017 8:51 AM PDT

The Burden of Brain Disorders

When the task of researching devastating neurological diseases like dementia, Parkinson’s, ALS and other neurodegenerative disorders is considered, the focus is on finding possible causes and hopefully treatments. Even when research doesn’t yield a perfect result, the information gained can be valuable in other ways, such as the development of new research techniques or lab procedures. The matter of cost is not always considered, beyond the always difficult pursuit of grant money and other resources to fund research. It’s a valid concern however because the cost of  treating many neurological diseases, in just the United States, was recently calculated at nearly $800 billion in 2014 dollars.

A report, published recently in the Annals of Neurology, looked at some of the more common neurological diseases and tallied up costs and found that when combined Alzheimer's disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson's disease, are putting a crushing burden on not only the national economy, but on families who must deal with the costs of caring for loved ones who are affected.

People are living longer, which is part of the rise in costs. The elderly are a demographic that has been trending upward and that rise shows no sign of slowing down. Estimates are that the number of elderly citizens will double by the year 2050 compared to the numbers in 2011.  Just taking two of the conditions examined, stroke and dementia, costs are estimated to reach $600 billion by the year 2030.

Lead author of the report, Dr. Clifton Gooch stated in a press release,"The findings of this report are a wake-up call for the nation, as we are facing an already incredible financial burden that is going to rapidly worsen in the coming years. Although society continues to reap the benefits of the dramatic research investments in heart disease and cancer over the last few decades, similar levels of investment are required to fund neuroscience research focused on curing devastating neurological diseases such as stroke and Alzheimer's, both to help our patients and also to avoid costs so large they could destabilize the entire health care system and the national economy."

Earlier research in a report published in July 2016 by the Information Technology and Innovation Foundation, puts the cost at an even higher number, $1.2 trillion, when psychiatric disorders are added to the tally. In a statement from that organization, Adams Nager, ITIF economic policy analyst and the report’s lead author explained, “Tens of millions of Americans suffer from a variety of mental and neurological health conditions each year. Besides the very significant human costs, these conditions also have a large impact on the U.S. economy. When you factor in both direct expenditures like treatment and reduced workforce participation, plus indirect costs like social services, the bottom line is staggering.”

The American Neurology Association report also included an action plan for addressing the issue including better clinical management of neurological disorders and improving facilities and infrastructure for neuroscience research. The full report, including a detailed graphic breaking down the costs for individual disorders can be found here and this video below explains more about the research.

 

Sources: Annals of Neurology, UPI, Information Technology and Innovation Foundation 

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 23, 2019
Drug Discovery & Development
NOV 23, 2019
Drug Seeks To Target Treatment-Resistant Epilepsy
Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? U...
NOV 25, 2019
Drug Discovery & Development
NOV 25, 2019
Discovery of mechanism behind Alexander disease may lead to enhanced drug development
Researchers have long known that the cause behind Alexander disease is a genetic culprit—mainly a mutation leading to the production of a defective p...
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...
JAN 17, 2020
Genetics & Genomics
JAN 17, 2020
Soybean Oil Found to Change Gene Expression in the Brain
Soybean oil is used for frying and for making foods like margarine and salad dressing. It's the most commonly produced and consumed edible oil in the US....
JAN 20, 2020
Neuroscience
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
FEB 12, 2020
Cannabis Sciences
FEB 12, 2020
Smoking Marijuana Leads to False Memory Formation
Smoking marijuana is known to make people forgetful. Now however, research has shown that smoking the substance may also make people remember things that n...
Loading Comments...